Related Experiment Video
Updated: Jan 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Polyhexamethylene Biguanide and Nadifloxacin Self-Assembled Nanoparticles: Antimicrobial Effects against
Nor Fadhilah Kamaruzzaman1,2, Maria De Fatima Pina3, Alexandru Chivu4
1Department of Pathobiology and Population Science, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK. norfadhilah@umk.edu.my.
Abstract:
The treatment of skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) remains a challenge, partly due to localization of the bacteria inside the host's cells, where antimicrobial penetration and efficacy is limited. We formulated the cationic polymer polyhexamethylene biguanide (PHMB) with the topical antibiotic nadifloxacin and tested the activities against intracellular MRSA in infected keratinocytes. The PHMB/nadifloxacin nanoparticles displayed a size of 291.3 ± 89.6 nm, polydispersity index of 0.35 ± 0.04, zeta potential of +20.2 ± 4.8 mV, and drug encapsulation efficiency of 58.25 ± 3.4%. The nanoparticles killed intracellular MRSA, and relative to free polymer or drugs used separately or together, the nanoparticles displayed reduced toxicity and improved host cell recovery. Together, these findings show that PHMB/nadifloxacin nanoparticles are effective against intracellular bacteria and could be further developed for the treatment of skin and soft tissue infections.
Insights
New nanoparticles effectively treat intracellular MRSA infections. This formulation combines polyhexamethylene biguanide (PHMB) and nadifloxacin, showing reduced toxicity and improved host cell recovery for skin infection treatment.
Area of Science:
- Pharmacology
- Nanotechnology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) skin infections are challenging due to intracellular bacterial localization.
- Limited antimicrobial penetration and efficacy within host cells hinder treatment.
- Novel drug delivery systems are needed to overcome these limitations.
Purpose of the Study:
- To formulate and evaluate polyhexamethylene biguanide (PHMB)/nadifloxacin nanoparticles for treating intracellular MRSA infections.
- To assess the efficacy, toxicity, and host cell recovery of the developed nanoparticles.
Main Methods:
- Formulation of cationic polymer PHMB with topical antibiotic nadifloxacin into nanoparticles.
- Characterization of nanoparticle size, polydispersity index, zeta potential, and encapsulation efficiency.
- In vitro testing against intracellular MRSA in infected keratinocytes, assessing bacterial killing, toxicity, and host cell recovery.
Main Results:
- PHMB/nadifloxacin nanoparticles exhibited a size of 291.3 ± 89.6 nm, PDI of 0.35 ± 0.04, zeta potential of +20.2 ± 4.8 mV, and 58.25 ± 3.4% encapsulation efficiency.
- The nanoparticles demonstrated significant killing of intracellular MRSA.
- Compared to free agents, nanoparticles showed reduced toxicity and enhanced host cell recovery.
Conclusions:
- PHMB/nadifloxacin nanoparticles are effective against intracellular MRSA.
- This formulation offers a promising therapeutic strategy for skin and soft tissue infections.
- Further development of these nanoparticles could lead to improved treatment outcomes.
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
Oral Hypoglycemic Agents: Biguanides and Glitazones
Intracellular Signaling Cascades
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Resistivity

